Loading...
Docoh

NanoVibronix (NAOV)

News

From Benzinga Pro
NanoVibronix Q1 Sales $272.00K Up From $103.00K YoY
17 May 22
Earnings, News
NanoVibronix (NASDAQ:NAOV) reported $272.00 thousand in sales this quarter. This is a 164.08 percent increase over sales of $103.00 thousand the same period last year.
NanoVibronix Reports FDA 510(k) Submission For PainShield MD Plus
4 May 22
Biotech, News, FDA, General
NanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has submitted a
NanoVibronix Reports Received Publication Guidance From National Institute For Health, Care Excellence With Recommendations For Co.'s UroShield Device
5 Apr 22
Biotech, News, FDA, General
NanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has received
12 Health Care Stocks Moving In Wednesday's Intraday Session
30 Mar 22
Intraday Update, Markets, Movers
Health Canada Approves NanoVibronix's PainGuard, UroGuard As Licensed Devices
30 Mar 22
News, Penny Stocks, Health Care, Movers, Trading Ideas, General
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
30 Mar 22
Movers
Gainers Adagio Therapeutics (NASDAQ:ADGI) shares increased by 52.2% to $5.86 during Wednesday's pre-market session. The company's market cap stands at $651.9 million.
NanoVibronix Announces PainGuard And UroGuard Approved By Health Canada As Licensed Medical Devices
30 Mar 22
Biotech, News, Health Care, FDA, General
Increases Opportunity for Broader International Distribution NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable

Press releases

From Benzinga Pro
NanoVibronix Reports First Quarter 2022 Financial Results
17 May 22
Press Releases
Expanded Distribution, Entry into New Geographic Markets and Regulatory Approvals Advancing Efforts Towards Full Commercialization NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company's
NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS
4 May 22
Press Releases
NanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has submitted a
Cerro de Pasco Announces MCTO and New Chief Financial Officer
29 Apr 22
Press Releases
MONTREAL, April 29, 2022 /CNW Telbec/ - Cerro de Pasco Resources Inc. (CSE:CDPR) (Frankfurt: N8HP) ("CDPR" or the "Company") announces that it has applied to the Autorité des marchés financiers (Québec)
NanoVibronix Adds Additional Product to Federal Supply Schedule
25 Apr 22
Press Releases
PainShield Plus and PainShield Monthly Kits Join UroShield and PainShield MD with Access to VA Market NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company that produces the UroShield®, PainShield® and
NanoVibronix Advances Efforts to Achieve NHS Approval
5 Apr 22
Press Releases
UroShield Receives Positive Guidance from NHS NanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic
NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices
30 Mar 22
Press Releases
Increases Opportunity for Broader International Distribution NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable